Propranolol Hydrochloride NDC 72189-074

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-074Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0074Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-074-30	72189007430	30 TABLET in 1 BOTTLE (72189-074-30)Marketed from Jun 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Propranolol Hydrochloride
Generic name (nonproprietary): propranolol hydrochloride
Active ingredients: Propranolol hydrochloride — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: DIRECT RX
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070217
Marketing start: Jun 16, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 72189-074_2be818df-f32a-45a2-e063-6294a90a334aSPL ID 2be818df-f32a-45a2-e063-6294a90a334aSPL set ID a834d1cf-72fc-93bf-e053-2995a90a6191RxCUI 856448UNII F8A3652H1V
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189007430 followed by a unit qualifier and the quantity

Package 72189-0074-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2025.

Indications (excerpt from the label)

Hypertension Propranolol hydrochloride tablets, USP are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride tablets, USP are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride tablets, USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol hydrochloride tablets, USP are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial In…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070217

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070217
Product	Strength	Form · route	Labeler	Product NDC
Propranolol Hydrochloride	Propranolol hydrochloride 10 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	66267-261